Asset Dedication LLC’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Asset Dedication LLC’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,605	Closed	-$79K	–	675
2018 Q1	$79K	Hold	1,605	–	–	0.04%	195
2017 Q4	$83K	Hold	1,605	–	–	0.03%	193
2017 Q3	$84K	Hold	1,605	–	–	0.04%	167
2017 Q2	$83K	Hold	1,605	–	–	0.04%	174
2017 Q1	$81K	Hold	1,605	–	–	0.04%	174
2016 Q4	$76K	Sell	1,605 -564	-26%	-$26.8K	0.04%	175
2016 Q3	$108K	Buy	2,169 +564	+35%	+$28.6K	0.07%	148
2016 Q2	$77K	Hold	1,605	–	–	0.05%	167
2016 Q1	$73K	Sell	1,605 -564	-26%	-$26.4K	0.05%	156
2015 Q4	$117K	Buy	+2,169	New	+$114K	0.08%	170

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Asset Dedication LLC's IHE Position: Q2 2018 in Review

Asset Dedication LLC sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2018, closing a stake of 1,605 shares — an estimated $79K sold.

Asset Dedication LLC first reported a position in IHE in Q4 2015 and held it in 10 quarters. The position peaked at $117K in Q4 2015. 95 funds tracked by Wall St. Rank hold IHE as of Q2 2018.

Asset Dedication LLC reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
Asset Dedication LLC sold 1,605 iShares US Pharmaceuticals ETF shares in Q2 2018, an estimated $79K.
Asset Dedication LLC first reported a position in iShares US Pharmaceuticals ETF in Q4 2015 and held it in 10 quarters.
Asset Dedication LLC's iShares US Pharmaceuticals ETF position peaked at $117K in Q4 2015.
95 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2018.

Based on Asset Dedication LLC's 13F filing for Q2 2018, filed 13 Aug 2018.